Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Strata Critical MedicalSRTA +1.51%71 3-1 Month Momentum % is -17.78% as of Aug. 25, 2026. GuruFocus rates SRTA with a GF Score™ of 71/100 and a GF Value™ of $4.77 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Strata Critical Medical ranks worse than 80.9% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-25), Strata Critical Medical's 3-1 Month Momentum % is -17.78%.
The industry rank for Strata Critical Medical's 3-1 Month Momentum % or its related term are showing as below:
SRTA's 3-1 Month Momentum % is ranked worse than 80.9% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: -2.08
vs SRTA: -17.78
Strata Critical Medical (NAS:SRTA) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Strata Critical Medical 3-1 Month Momentum % Related Terms
SRTA vs CCRN, CYH, TOI: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Strata Critical Medical's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Critical Medical 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Strata Critical Medical's 3-1 Month Momentum % falls into.
Strata Critical Medical (NAS:SRTA) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Critical Medical (SRTA) has a 3-1 Month Momentum % of -17.78% as of Aug. 25, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Strata Critical Medical and its competitors. According to the industry distribution chart, Strata Critical Medical ranks #538 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 80.9%.
Is Strata Critical Medical's 3-1 Month Momentum % too high?
Strata Critical Medical's current 3-1 Month Momentum % is -17.78%. Based on the distribution chart, Strata Critical Medical ranks #538 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Strata Critical Medical has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's 3-1 Month Momentum % compare to CCRN and CYH?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #538 out of 665 companies for 3-1 Month Momentum %. This places Strata Critical Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Strata Critical Medical and its competitors. Strata Critical Medical's current 3-1 Month Momentum % is -17.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.77, compared to a current price of $6.06 — trading 26.9% above its estimated fair value. The current 3-1 Month Momentum % is -17.78%. Strata Critical Medical's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current 3-1 Month Momentum % is -17.78% as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Critical Medical (SRTA) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued.
The current stock price of $6.06 is trading 26.9% above its estimated GF Value™ of $4.77.
GuruFocus considers Strata Critical Medical to be Modestly Overvalued.
Key valuation signals for SRTA:
3-1 Month Momentum %: -17.78%
GF Value™: $4.77 vs. price of $6.06 (26.9% above fair value)
No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
71GF Score
Get the complete analysis for SRTA
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTA has been successfully added to your 
